1.3K views · 96 reactions | The Wyss adeno-associated virus (AAV) team led by George Church is exploring the great potential of AAV as a gene delivery tool and rapidly engineering it into a new and improved vector entity that is able to accommodate the demands and the development pace of safe gene therapy technologies. Learn more here: https://wyss.harvard.edu/technology/aav-engineering-for-advanced-gene-therapy/ | Wyss Institute for Biologically Inspired Engineering at Harvard | Facebook